Kiio and Quartz Health Solutions’ Low Back Pain Study Demonstrates the Success of Digital Therapeutic in Lowering Costs and Improving Outcomes


Program Dramatically Cut Medical Spending; Reduced Utilization of ED, Urgent Care, Aggressive Treatment and Diagnostics; and Decreased Fills for Opioid Prescriptions

 

Madison, Wis. (September 10, 2018) – Today, Kiio and Quartz Health Solutions unveiled the results of a one-year study to evaluate the impact of Kiio’s digital program on the challenges presented by low back pain. Low back pain affects one in three American adults every year and costs the U.S. over $100 billion annually. The study demonstrates success improving the lives of patients living with chronic pain while reducing medical spend and the danger of opioids. Quartz offered Kiio to plan members with a history of low back pain. Read about the significant improvements experienced by Kiio participants.

Kiio to present at Pittsburgh Business Group on Health Sept. 6


Low back pain is the number one cause of opioid prescriptions and a leading driver of employment costs.

This is especially relevant given the increasing threat opioids have had on our communities in recent years.

Kiio CEO Dave Grandin and VP Product Strategy Lydia Zeller will present Kiio’s digital solution for back pain Sept. 6th at Pittsburgh Business Group on Health’s 2018 Symposium, Accelerate the New Era of Healthcare.

Dave and Lydia will share details on how Kiio is delivering a 24/7, consumer-centric solution proven to improve health and empower individuals, while reducing use of opioids and aggressive medical treatments. The presentation will include Kiio’s clinical and financial outcomes.

To register for the event, to be held at the Pittsburgh Marriott City Center, click here.